Advertisement

Pulmonx Corporation LUNG

Set alert

Price alert · LUNG

All alert types
3.01 USD -0.16 -5.06%

At close · Oct 30

2.98 -0.02 -0.83%

After hours · Oct 30, 7:48 PM ET

Bid
3.00 × 2
Ask
3.01 × 3
2.79 Day range 3.23
1.17 52-week range 3.16
YTD
+35.97%
1 year
+70.74%
Open
3.07
Prev close
3.17
Mkt cap
126.92M
Vol
2.41M
Avg vol
618.68K
EPS
-1.01
P/E
0.00
Div yield
0.00%
More statistics
Low
2.79
High
3.23
Forward P/E
-3.91
Beta
0.68
Short ratio
3.62
Inst. own
94.86%
Dividend
0.00
Ex-div date
Earnings
Jul 31, 2024
50-d avg
6.51
200-d avg
7.33
1y target
11.92

MAX chart

Chart tools
Interval

Events in this range
  • Feb 21, 2024Earnings: —; estimate -0.39; surprise —%
  • May 1, 2024Earnings: -0.36; estimate -0.43; surprise 16.28%
  • May 1, 2024Earnings: —; estimate -0.43; surprise —%
  • Jul 31, 2024Earnings: -0.39; estimate -0.41; surprise 4.88%
  • Jul 31, 2024Earnings: —; estimate -0.41; surprise —%
  • Aug 1, 2024Rating: Wells Fargo · Equal-Weight → Equal-Weight
  • Aug 1, 2024Rating: Canaccord Genuity · Buy → Buy
  • Aug 1, 2024Rating: Piper Sandler · Overweight → Overweight
  • Oct 30, 2024Earnings: -0.36; estimate -0.43; surprise 16.28%
  • Oct 31, 2024Rating: Stifel · Buy → Buy
  • Dec 11, 2024Downgrade: Citigroup · Buy → Neutral
  • Dec 11, 2024Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (116)
NameDateAgo
SMA: BullishOct 26, 20266 days ago
MACD: Buy SignalOct 26, 20266 days ago
MACD: Sell SignalOct 12, 20262 weeks ago
SMA: BearishSep 21, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 7, 20261 month ago
SMA: BullishJul 27, 20263 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishMay 18, 20265 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BullishMar 2, 20268 months ago
SMA: BullishMar 2, 20268 months ago
SMA: BearishJan 12, 20269 months ago
SMA: BullishDec 8, 202510 months ago
SMA: BullishDec 1, 202511 months ago
SMA: BearishNov 10, 202511 months ago
SMA: BullishOct 27, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BullishSep 29, 20251 year ago
MACD: Buy SignalSep 8, 20251 year ago
SMA: BearishJul 28, 20251 year ago
MACD: Sell SignalJul 28, 20251 year ago
RSI: OversoldJul 28, 20251 year ago
MACD: Buy SignalJul 21, 20251 year ago
SMA: BullishJul 14, 20251 year ago
MACD: Sell SignalApr 7, 20251 year ago
SMA: BearishMar 24, 20251 year ago
SMA: BearishMar 24, 20251 year ago
SMA: BullishFeb 10, 20251 year ago
SMA: BullishFeb 3, 20251 year ago
MACD: Buy SignalFeb 3, 20251 year ago
MACD: Sell SignalJan 27, 20251 year ago
SMA: BearishJan 13, 20251 year ago
SMA: BullishDec 23, 20241 year ago
MACD: Buy SignalDec 23, 20241 year ago
MACD: Sell SignalDec 9, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BullishNov 4, 20241 year ago
MACD: Buy SignalNov 4, 20241 year ago
MACD: Sell SignalOct 28, 20242 years ago
SMA: BearishSep 30, 20242 years ago
SMA: BearishSep 30, 20242 years ago
SMA: BullishSep 9, 20242 years ago
SMA: BullishAug 19, 20242 years ago
SMA: BearishJul 29, 20242 years ago
MACD: Buy SignalJul 15, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BearishMay 20, 20242 years ago
SMA: BullishMay 13, 20242 years ago
SMA: BearishMay 6, 20242 years ago
SMA: BullishApr 29, 20242 years ago
MACD: Sell SignalFeb 26, 20242 years ago
SMA: BearishFeb 19, 20242 years ago
SMA: BearishFeb 19, 20242 years ago
SMA: BullishNov 27, 20232 years ago
MACD: Buy SignalNov 20, 20232 years ago
SMA: BullishNov 13, 20232 years ago
SMA: BearishNov 6, 20232 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BearishAug 7, 20233 years ago
SMA: BearishAug 7, 20233 years ago
MACD: Sell SignalAug 7, 20233 years ago
SMA: BullishJul 24, 20233 years ago
SMA: BearishJul 17, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BearishJul 3, 20233 years ago
SMA: BullishMay 29, 20233 years ago
SMA: BearishMay 22, 20233 years ago
SMA: BullishMar 13, 20233 years ago
SMA: BearishMar 6, 20233 years ago
SMA: BullishFeb 27, 20233 years ago
MACD: Buy SignalJan 2, 20233 years ago
SMA: BullishDec 26, 20223 years ago
RSI: OversoldOct 31, 20224 years ago
MACD: Sell SignalOct 17, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BullishSep 5, 20224 years ago
SMA: BearishAug 29, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishAug 8, 20224 years ago
SMA: BullishJul 25, 20224 years ago
MACD: Buy SignalJul 18, 20224 years ago
RSI: OversoldJun 13, 20224 years ago
MACD: Sell SignalMay 9, 20224 years ago
SMA: BearishApr 25, 20224 years ago
SMA: BullishMar 28, 20224 years ago
MACD: Buy SignalMar 28, 20224 years ago
SMA: BearishMar 21, 20224 years ago
SMA: BullishMar 14, 20224 years ago
MACD: Sell SignalNov 22, 20214 years ago
SMA: BearishNov 15, 20214 years ago
SMA: BearishNov 8, 20214 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BearishOct 25, 20215 years ago
SMA: BullishOct 11, 20215 years ago
SMA: BearishSep 6, 20215 years ago
SMA: BullishAug 30, 20215 years ago
MACD: Buy SignalAug 30, 20215 years ago
SMA: BearishAug 9, 20215 years ago
SMA: BullishAug 2, 20215 years ago
SMA: BearishJul 5, 20215 years ago
SMA: BullishJun 21, 20215 years ago
SMA: BearishJun 14, 20215 years ago
SMA: BullishJun 7, 20215 years ago
SMA: BearishMar 15, 20215 years ago
SMA: BullishMar 8, 20215 years ago
SMA: BearishFeb 8, 20215 years ago
SMA: BullishFeb 1, 20215 years ago
SMA: BearishJan 25, 20215 years ago
RSI: OverboughtJan 18, 20215 years ago

Key statistics

Market cap
247.19M
Enterprise value
190.88M
Trailing P/E
0.00
Forward P/E
-3.91
PEG ratio
0.00
Price / sales
3.12
Price / book
2.63
EPS (TTM)
-1.47
Beta
0.68
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-72.01%
Revenue (TTM)
79.30M
Revenue growth
15.40%
Free cash flow
-14.47M
Total cash
107.78M
Total debt
55.81M
Return on equity
-51.99%
Shares outstanding
39.49M
Short % of float
2.92%
50-day average
6.51
200-day average
7.33

Analyst view

Consensus: buy

Buy
Price target (mean) 11.92 +296.6% upside
Target (low)
7.50
Target (mean)
11.92
Target (high)
16.00
Ratings (0m) 6 4 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Jul 31, 2024

Expected Jul 31, 2024. Consensus EPS estimate -0.44894.

Earnings history

Financials — quick view

All financials
LUNG Revenue — quarterly 22.76M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LUNG Net income — quarterly -10.08M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LUNG EPS — quarterly -0.24
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

LUNG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 30, 2024Sep 1, 2024-0.43-0.36+0.07+16.28%
Jul 31, 2024Jun 1, 2024-0.41-0.39+0.02+4.88%
Jul 31, 2024Jun 1, 2024-0.41———
May 1, 2024Mar 1, 2024-0.43-0.36+0.07+16.28%
May 1, 2024Mar 1, 2024-0.43———
Feb 21, 2024Dec 1, 2023-0.39———

Upgrades / downgrades

LUNG analyst upgrades and downgrades
DateFirmActionFromTo
Dec 11, 2024Wells FargomainEqual-WeightEqual-Weight
Dec 11, 2024CitigroupdownBuyNeutral
Oct 31, 2024StifelmainBuyBuy
Aug 1, 2024Piper SandlermainOverweightOverweight
Aug 1, 2024Canaccord GenuitymainBuyBuy
Aug 1, 2024Wells FargomainEqual-WeightEqual-Weight

About Pulmonx Corporation

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
pulmonx.com

News

Your note

Sign in to keep a note on LUNG — it syncs with the Stock Master app.

Insider holders

LUNG insider holders
InsiderRelationLatest transactionDateShares held
BURNS THOMAS WILLIAMDirectorStock Award(Grant)Jun 2, 202436,246
FERRARI RICHARD MDirectorStock Award(Grant)Jun 2, 202457,871
FLORIN DANIEL PDirectorStock Award(Grant)Jun 2, 202456,757
FRENCH GLENDON E IIIDirectorSaleNov 21, 20241,071,970
LEHMAN DAVID AARONGeneral CounselSaleDec 1, 2024197,851
MEAD DANA G JRDirectorStock Award(Grant)Jun 2, 202466,637

Institution ownership

LUNG institution ownership
Holder% heldSharesValueReported
FMR, LLC14.87%5,872,88236.76MSep 29, 2024
Primecap Management Company14.37%5,676,01135.53MSep 29, 2024
Morgan Stanley9.60%3,788,94523.72MSep 29, 2024
Blackrock Inc.7.08%2,795,56117.50MSep 29, 2024
Vanguard Group Inc5.77%2,278,90514.27MSep 29, 2024
Deutsche Bank Aktiengesellschaft2.84%1,121,8407.02MSep 29, 2024

Fund ownership

LUNG fund ownership
Holder% heldSharesValueReported
Primecap Odyssey Aggressive Growth Fund9.78%3,861,21624.17MSep 29, 2024
Fidelity Small Cap Growth Fund3.78%1,493,4729.35MAug 30, 2024
Fidelity Select Portfolios - Pharmaceuticals3.63%1,431,5228.96MOct 30, 2024
Vanguard Total Stock Market Index Fund2.94%1,161,6717.27MSep 29, 2024
iShares Russell 2000 ETF2.48%978,9306.13MOct 30, 2024
Fidelity Advisor Small Cap Fund2.11%832,4005.21MAug 30, 2024
Advertisement